Association of BST1 polymorphism with idiopathic restless legs syndrome in Chinese population

Zurück zum Zitat Krishnan PR, Bhatia M, Behari M (2003) Restless legs syndrome in Parkinson’s disease: a case-controlled study. Mov Disord 18:181–185CrossRef Krishnan PR, Bhatia M, Behari M (2003) Restless legs syndrome in Parkinson’s disease: a case-controlled study. Mov Disord 18:181–185CrossRef

Zurück zum Zitat Nomura T, Inoue Y, Miyake M, Yasui K, Nakashima K (2006) Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 21:380–384CrossRef Nomura T, Inoue Y, Miyake M, Yasui K, Nakashima K (2006) Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 21:380–384CrossRef

Zurück zum Zitat Walters AS, LeBrocq C, Passi V, Patel S, Hanna PA, Cohen B, Wagner M (2003) A preliminary look at the percentage of patients with restless legs syndrome who also have Parkinson disease, essential tremor or Tourette syndrome in a single practice. J Sleep Res 12:343–345CrossRef Walters AS, LeBrocq C, Passi V, Patel S, Hanna PA, Cohen B, Wagner M (2003) A preliminary look at the percentage of patients with restless legs syndrome who also have Parkinson disease, essential tremor or Tourette syndrome in a single practice. J Sleep Res 12:343–345CrossRef

Zurück zum Zitat Wong JC, Li Y, Schwarzschild MA, Ascherio A, Gao X (2014) Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep 37:369–372CrossRef Wong JC, Li Y, Schwarzschild MA, Ascherio A, Gao X (2014) Restless legs syndrome: an early clinical feature of Parkinson disease in men. Sleep 37:369–372CrossRef

Zurück zum Zitat Alonso-Navarro H, García-Martín E, Agúndez JAG, Jiménez-Jiménez FJ (2019) Association between restless legs syndrome and other movement disorders. Neurology 92:948–964CrossRef Alonso-Navarro H, García-Martín E, Agúndez JAG, Jiménez-Jiménez FJ (2019) Association between restless legs syndrome and other movement disorders. Neurology 92:948–964CrossRef

Zurück zum Zitat Calzetti S, Angelini M, Negrotti A, Marchesi E, Goldoni M (2014) A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson’s disease. J Neural Transm (Vienna) 121:499–506CrossRef Calzetti S, Angelini M, Negrotti A, Marchesi E, Goldoni M (2014) A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson’s disease. J Neural Transm (Vienna) 121:499–506CrossRef

Zurück zum Zitat Marchesi E, Negrotti A, Angelini M, Goldoni M, Abrignani G, Calzetti S (2016) A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson’s disease during chronic dopaminergic therapy. J Neurol 263:441–447CrossRef Marchesi E, Negrotti A, Angelini M, Goldoni M, Abrignani G, Calzetti S (2016) A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson’s disease during chronic dopaminergic therapy. J Neurol 263:441–447CrossRef

Zurück zum Zitat Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy O, Mirelman A, Gana-Weisz M, Dupré N, Montplaisir J, Giladi N, Fahn S, Xiong L, Dion PA, Orr-Urtreger A, Rouleau GA (2015) Genetic markers of restless legs syndrome in Parkinson disease. Parkinsonism Relat Disord 21:582–585CrossRef Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy O, Mirelman A, Gana-Weisz M, Dupré N, Montplaisir J, Giladi N, Fahn S, Xiong L, Dion PA, Orr-Urtreger A, Rouleau GA (2015) Genetic markers of restless legs syndrome in Parkinson disease. Parkinsonism Relat Disord 21:582–585CrossRef

Zurück zum Zitat Mohtashami S, He Q, Ruskey JA, Zhou S, Dion PA, Allen RP, Earley CJ, Fon EA, Xiong L, Dupre N, Dauvilliers Y, Rouleau GA, Gan-Or Z (2018) TOX3 variants are involved in restless legs syndrome and Parkinson’s disease with opposite effects. J Mol Neurosci 64:341–345CrossRef Mohtashami S, He Q, Ruskey JA, Zhou S, Dion PA, Allen RP, Earley CJ, Fon EA, Xiong L, Dupre N, Dauvilliers Y, Rouleau GA, Gan-Or Z (2018) TOX3 variants are involved in restless legs syndrome and Parkinson’s disease with opposite effects. J Mol Neurosci 64:341–345CrossRef

Zurück zum Zitat Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15:860–873CrossRef Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, Zucconi M, Ferri R, Trenkwalder C, Lee HB, International Restless Legs Syndrome Study Group (2014) Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med 15:860–873CrossRef

Zurück zum Zitat García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ, International Restless Legs Syndrome Study Group (2007) Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 8:520–530CrossRef García-Borreguero D, Allen RP, Kohnen R, Högl B, Trenkwalder C, Oertel W, Hening WA, Paulus W, Rye D, Walters A, Winkelmann J, Earley CJ, International Restless Legs Syndrome Study Group (2007) Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 8:520–530CrossRef

Zurück zum Zitat Ahmad NN, Cu-Unjieng AB, Donoso LA (1995) Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet 32:129–130CrossRef Ahmad NN, Cu-Unjieng AB, Donoso LA (1995) Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet 32:129–130CrossRef

Zurück zum Zitat Guo JF, Li K, Yu RL et al (2015) Polygenic determinants of Parkinson’s disease in a Chinese population. Neurobiol Aging 36:1765.e1761–1765.e1766 Guo JF, Li K, Yu RL et al (2015) Polygenic determinants of Parkinson’s disease in a Chinese population. Neurobiol Aging 36:1765.e1761–1765.e1766

Zurück zum Zitat Yokoyama S, Al Mahmuda N, Munesue T et al (2015) Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population. Brain Sci 5:188–200CrossRef Yokoyama S, Al Mahmuda N, Munesue T et al (2015) Association study between the CD157/BST1 gene and autism spectrum disorders in a Japanese population. Brain Sci 5:188–200CrossRef

Zurück zum Zitat D’Souza T, Rajkumar AP (2020) Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson’s disease. Acta Neuropsychiatr 32:10–22CrossRef D’Souza T, Rajkumar AP (2020) Systematic review of genetic variants associated with cognitive impairment and depressive symptoms in Parkinson’s disease. Acta Neuropsychiatr 32:10–22CrossRef

Zurück zum Zitat Yuan L, Song Z, Deng X, Xiong W, Yang Z, Deng H (2016) Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson’s disease patients. Neurosci Lett 616:26–31CrossRef Yuan L, Song Z, Deng X, Xiong W, Yang Z, Deng H (2016) Association of the MTHFR rs1801131 and rs1801133 variants in sporadic Parkinson’s disease patients. Neurosci Lett 616:26–31CrossRef

Zurück zum Zitat Khaligh A, Goudarzian M, Moslem A, Mehrtash A, Jamshidi J, Darvish H, Emamalizadeh B (2017) RAB7L1 promoter polymorphism and risk of Parkinson’s disease; a case-control study. Neurol Res 39:468–471CrossRef Khaligh A, Goudarzian M, Moslem A, Mehrtash A, Jamshidi J, Darvish H, Emamalizadeh B (2017) RAB7L1 promoter polymorphism and risk of Parkinson’s disease; a case-control study. Neurol Res 39:468–471CrossRef

Zurück zum Zitat Wang L, Cheng L, Lu ZJ, Sun XY, Li JY, Peng R (2016) Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson’s disease in Han Chinese. J Neural Transm (Vienna) 123:425–430CrossRef Wang L, Cheng L, Lu ZJ, Sun XY, Li JY, Peng R (2016) Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson’s disease in Han Chinese. J Neural Transm (Vienna) 123:425–430CrossRef

Zurück zum Zitat Zhu XC, Cao L, Tan MS, Jiang T, Wang HF, Lu H, Tan CC, Zhang W, Tan L, Yu JT (2017) Association of Parkinson’s disease GWAS-linked loci with Alzheimer’s disease in Han Chinese. Mol Neurobiol 54:308–318CrossRef Zhu XC, Cao L, Tan MS, Jiang T, Wang HF, Lu H, Tan CC, Zhang W, Tan L, Yu JT (2017) Association of Parkinson’s disease GWAS-linked loci with Alzheimer’s disease in Han Chinese. Mol Neurobiol 54:308–318CrossRef

Zurück zum Zitat Cheng L, Wang L, Li NN, Yu WJ, Sun XY, Li JY, Zhou D, Peng R (2016) SNCA rs356182 variant increases risk of sporadic Parkinson’s disease in ethnic Chinese. J Neurol Sci 368:231–234CrossRef Cheng L, Wang L, Li NN, Yu WJ, Sun XY, Li JY, Zhou D, Peng R (2016) SNCA rs356182 variant increases risk of sporadic Parkinson’s disease in ethnic Chinese. J Neurol Sci 368:231–234CrossRef

Zurück zum Zitat Hou B, Zhang X, Liu Z, Wang J, Xie A (2019) Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson’s disease: a meta-analysis. Neurosci Lett 709:134380CrossRef Hou B, Zhang X, Liu Z, Wang J, Xie A (2019) Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson’s disease: a meta-analysis. Neurosci Lett 709:134380CrossRef

Zurück zum Zitat Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM (2010) Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 31:561–568PubMed Tan EK, Peng R, Teo YY, Tan LC, Angeles D, Ho P, Chen ML, Lin CH, Mao XY, Chang XL, Prakash KM, Liu JJ, Au WL, le WD, Jankovic J, Burgunder JM, Zhao Y, Wu RM (2010) Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 31:561–568PubMed

Zurück zum Zitat Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R (2009) Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson’s disease. BMC Neurol 9:26CrossRef Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R (2009) Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson’s disease. BMC Neurol 9:26CrossRef

Zurück zum Zitat Chang D, Nalls MA, Hallgrímsdóttir IB et al (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49:1511–1516CrossRef Chang D, Nalls MA, Hallgrímsdóttir IB et al (2017) A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat Genet 49:1511–1516CrossRef

Zurück zum Zitat Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Pütz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39:1000–1006CrossRef Winkelmann J, Schormair B, Lichtner P, Ripke S, Xiong L, Jalilzadeh S, Fulda S, Pütz B, Eckstein G, Hauk S, Trenkwalder C, Zimprich A, Stiasny-Kolster K, Oertel W, Bachmann CG, Paulus W, Peglau I, Eisensehr I, Montplaisir J, Turecki G, Rouleau G, Gieger C, Illig T, Wichmann HE, Holsboer F, Müller-Myhsok B, Meitinger T (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39:1000–1006CrossRef

Zurück zum Zitat Peeraully T, Tan EK (2012) Genetic variants in sporadic Parkinson’s disease: East vs West. Parkinsonism Relat Disord 18(Suppl 1):S63–S65CrossRef Peeraully T, Tan EK (2012) Genetic variants in sporadic Parkinson’s disease: East vs West. Parkinsonism Relat Disord 18(Suppl 1):S63–S65CrossRef

Zurück zum Zitat Higashida H, Hashii M, Tanaka Y, Matsukawa S, Higuchi Y, Gabata R, Tsubomoto M, Seishima N, Teramachi M, Kamijima T, Hattori T, Hori O, Tsuji C, Cherepanov SM, Shabalova AA, Gerasimenko M, Minami K, Yokoyama S, Munesue SI, Harashima A, Yamamoto Y, Salmina AB, Lopatina O (2019) CD38, CD157, and RAGE as molecular determinants for social behavior. Cells 9 Higashida H, Hashii M, Tanaka Y, Matsukawa S, Higuchi Y, Gabata R, Tsubomoto M, Seishima N, Teramachi M, Kamijima T, Hattori T, Hori O, Tsuji C, Cherepanov SM, Shabalova AA, Gerasimenko M, Minami K, Yokoyama S, Munesue SI, Harashima A, Yamamoto Y, Salmina AB, Lopatina O (2019) CD38, CD157, and RAGE as molecular determinants for social behavior. Cells 9

Zurück zum Zitat Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA, Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AFR, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, di Angelantonio E, Hinds DA, Müller-Myhsok B, Winkelmann J, Balkau B, Ducimetière P, Eschwège E, Rancière F, Alhenc-Gelas F, Gallois Y, Girault A, Fumeron F, Marre M, Roussel R, Bonnet F, Bonnefond A, Cauchi S, Froguel P, Cogneau J, Born C, Caces E, Cailleau M, Lantieri O, Moreau JG, Rakotozafy F, Tichet J, Vol S, Agee M, Alipanahi B, Auton A, Bell RK, Bryc K, Elson SL, Fontanillas P, Furlotte NA, Hinds DA, Hromatka BS, Huber KE, Kleinman A, Litterman NK, McIntyre MH, Mountain JL, Northover CAM, Pitts SJ, Sathirapongsasuti JF, Sazonova OV, Shelton JF, Shringarpure S, Tian C, Tung JY, Vacic V, Wilson CH (2017) Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol 16:898–907CrossRef Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Teder-Laving M, Metspalu A, Hadjigeorgiou GM, Polo O, Fietze I, Ross OA, Wszolek Z, Butterworth AS, Soranzo N, Ouwehand WH, Roberts DJ, Danesh J, Allen RP, Earley CJ, Ondo WG, Xiong L, Montplaisir J, Gan-Or Z, Perola M, Vodicka P, Dina C, Franke A, Tittmann L, Stewart AFR, Shah SH, Gieger C, Peters A, Rouleau GA, Berger K, Oexle K, di Angelantonio E, Hinds DA, Müller-Myhsok B, Winkelmann J, Balkau B, Ducimetière P, Eschwège E, Rancière F, Alhenc-Gelas F, Gallois Y, Girault A, Fumeron F, Marre M, Roussel R, Bonnet F, Bonnefond A, Cauchi S, Froguel P, Cogneau J, Born C, Caces E, Cailleau M, Lantieri O, Moreau JG, Rakotozafy F, Tichet J, Vol S, Agee M, Alipanahi B, Auton A, Bell RK, Bryc K, Elson SL, Fontanillas P, Furlotte NA, Hinds DA, Hromatka BS, Huber KE, Kleinman A, Litterman NK, McIntyre MH, Mountain JL, Northover CAM, Pitts SJ, Sathirapongsasuti JF, Sazonova OV, Shelton JF, Shringarpure S, Tian C, Tung JY, Vacic V, Wilson CH (2017) Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol 16:898–907CrossRef

Zurück zum Zitat Lopatina O, Yoshihara T, Nishimura T et al (2014) Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson’s disease. Front Behav Neurosci 8:133CrossRef Lopatina O, Yoshihara T, Nishimura T et al (2014) Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson’s disease. Front Behav Neurosci 8:133CrossRef

Zurück zum Zitat Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson’s disease. Lancet Neurol 19:170–178CrossRef Blauwendraat C, Nalls MA, Singleton AB (2020) The genetic architecture of Parkinson’s disease. Lancet Neurol 19:170–178CrossRef

Zurück zum Zitat Kelada SN, Checkoway H, Kardia SL et al (2006) 5′ and 3′ region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson’s disease risk: a hypothesis-generating study. Hum Mol Genet 15:3055–3062CrossRef Kelada SN, Checkoway H, Kardia SL et al (2006) 5′ and 3′ region variability in the dopamine transporter gene (SLC6A3), pesticide exposure and Parkinson’s disease risk: a hypothesis-generating study. Hum Mol Genet 15:3055–3062CrossRef

Zurück zum Zitat Wu YR, Feng IH, Lyu RK et al (2007) Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet 144b:300–304CrossRef Wu YR, Feng IH, Lyu RK et al (2007) Tumor necrosis factor-alpha promoter polymorphism is associated with the risk of Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet 144b:300–304CrossRef

Zurück zum Zitat Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C (2004) CYP2D6 polymorphism, pesticide exposure, and Parkinson’s disease. Ann Neurol 55:430–434CrossRef Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C (2004) CYP2D6 polymorphism, pesticide exposure, and Parkinson’s disease. Ann Neurol 55:430–434CrossRef

Zurück zum Zitat Allen AS, Satten GA (2010) SNPs in CAST are associated with Parkinson disease: a confirmation study. Am J Med Genet B Neuropsychiatr Genet 153b:973–979PubMed Allen AS, Satten GA (2010) SNPs in CAST are associated with Parkinson disease: a confirmation study. Am J Med Genet B Neuropsychiatr Genet 153b:973–979PubMed

Zurück zum Zitat Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet 7:e1002141CrossRef Do CB, Tung JY, Dorfman E, Kiefer AK, Drabant EM, Francke U, Mountain JL, Goldman SM, Tanner CM, Langston JW, Wojcicki A, Eriksson N (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet 7:e1002141CrossRef